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Abstract 28 
PURPOSE: This study evaluated the change (Δ) in plasma volume (PV), nitrate [NO3-], and 29 
nitrite [NO2-] concentration following changes in posture in the presence and absence of 30 
elevated plasma [NO3-] and [NO2-]. METHODS: Fourteen healthy participants completed two 31 
trials that were preceded by either supplementation with NO3--rich beetroot juice (BR; total of 32 
~31 mmol NO3-) or no supplementation (CON). Both trials comprised 30 min of lying supine 33 
followed by 2 min of standing, 2 min of sitting and 5 min of sub-maximal cycling. 34 
Measurements of plasma [NO3-] and [NO2-] were made by gas-phase chemiluminescence and 35 
ΔPV was estimated using the Dill and Costill method. RESULTS: Plasma [NO2-] decreased 36 
from baseline (CON: 120 ± 49 nM, BR: 357 ± 129 nM) after lying supine for 30 min (CON 77 37 
± 30 nM; BR 231 ± 92 nM, both P<0.01) before increasing during standing (CON 109 ± 42 38 
nM; BR 297 ± 105 nM, both P<0.01) and sitting (CON 131 ± 43 nM; BR 385 ± 125 nM, both 39 
P<0.01). Plasma [NO2-] remained elevated following exercise only in CON (125 ± 61 nM 40 
P=0.02). Plasma [NO3-] was not different between measurement points in either condition 41 
(P>0.05). PV increased from baseline during the supine phase before decreasing upon standing, 42 
sitting, and exercise in both trials (all P<0.05). CONCLUSIONS: Changing body posture 43 
causes rapid and consistent alterations in plasma [NO2-]. Researchers should therefore carefully 44 
consider the effect of posture when measuring this variable.      45 
 46 
Key Words: beetroot juice, exercise, plasma volume    47 
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1. Introduction  48 
Nitric oxide (NO) is a ubiquitous signalling molecule which is synthesised endogenously from 49 
L-arginine by NO synthases (NOS) in the presence of oxygen (O2) and regulates a multitude of 50 
biological processes  (Forstermann and Sessa 2012). For example, NO is transiently released 51 
from endothelial cells, diffusing from the production site to smooth muscle cells, resulting in 52 
dilation of the vasculature (Ignarro et al. 1987). Nevertheless, the majority of NO does not 53 
reach its target cells due to rapid oxidation to nitrite (NO2-) and nitrate (NO3-) (Kelm 1999).  54 
However, when pO2 is reduced endogenous NO synthesis is diminished and can result in a 55 
reduced blood flow to the periphery (Lundberg et al. 2008). Under these conditions it has been 56 
shown that NO metabolites can be utilised as a reservoir for NO production via the NO3- - NO2- 57 
- NO pathway. Firstly, NO3- can be reduced to NO2- by facultative bacteria on the tongue 58 
(Duncan et al. 1995) via the entero-salivary system (Lundberg and Govoni 2004). The resultant 59 
NO2- is ingested and absorbed into the blood plasma where it may be reduced to NO under 60 
certain local physiological conditions (Lundberg et al. 1994; Millar et al. 1998; Modin et al. 61 
2001; Castello et al. 2006).  However, due to the short half-life of NO, plasma [NO2-] is still 62 
considered to provide the best approximation of vascular NO bioavailability (Kelm 1999; 63 
Lauer et al. 2001). Increased plasma [NO2-] is also associated with improved endothelial 64 
function (Rassaf et al. 2006) and superior exercise capacity (Totzeck et al. 2012) and is 65 
therefore routinely measured in cardiovascular and exercise science research. 66 
 67 
NO3- is also readily available within our diet and its consumption has been shown to 68 
significantly increase plasma [NO3-], and thus [NO2-]. There is now an abundance of research 69 
which has explored the potential therapeutic and ergogenic benefits of supplementation with 70 
dietary NO3- (Siervo and Lara 2013; Pawlak-Chaouch et al. 2016; McMahon et al. 2017). This 71 
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research typically encapsulates repeated measurements of physiological variables during 72 
periods of rest and exercise. During the experimental protocols, blood samples may be 73 
routinely collected while participants are either supine (Muggeridge et al. 2015), seated 74 
(Sandbakk et al. 2015), or standing (Wylie et al. 2013b).  However, it is well-established that 75 
alterations in posture lead to marked changes in plasma volume (PV) that can alter the 76 
molecular concentrations of common biochemical analytes (Thompson et al. 1928; Fawcett 77 
and Wynn 1960; Hagan et al. 1978; Hagan et al. 1980; Lippi et al. 2015). A probable 78 
explanation is that postural-induced alterations in hydrostatic pressure force fluid and protein 79 
to shift between the blood and interstitial space (Cohn 1966; Stokke et al. 1986). Lippi and 80 
colleagues (2015) report that PV was decreased by 3% and 14% when moving from a supine 81 
posture to sitting and standing, respectively. Furthermore, short duration high-intensity 82 
exercise  has been shown to decrease PV between 5-22 % in various exercise modalities 83 
(Kargotich et al. 1998). 84 
 85 
Previous research has shown considerable variability in the values of basal and supplemented 86 
plasma [NO3-] and [NO2-] (Wylie et al. 2013b; Muggeridge et al. 2015; Sandbakk et al. 2015; 87 
McMahon et al. 2017). Given that NO3- is measured in the micromolar range and NO2- in the 88 
nanomolar range, the measured concentration of these variables may be subject to postural-89 
induced changes. Indeed, we have recently shown that plasma [NO2-] declined significantly 90 
over a 30 min period while participants lay supine (Muggeridge et al. 2015), suggesting that 91 
posture and PV shifts may alter plasma [NO2-]. However, several factors exist which may 92 
account for these observations. For example, prolonged sitting is known to decrease shear 93 
stress, whereas standing may increase shear stress and endogenous NO production (Uematsu 94 
et al. 1995; Sessa 2004; Hsieh et al. 2014; Restaino et al. 2016; Morishima et al. 2017). This 95 
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demonstrates that further research is required to determine the impact of posture on NO 96 
metabolites. 97 
 98 
No study has explored the effects of postural changes on the measured concentrations of plasma 99 
[NO3-] and [NO2-]. The aim of the present study, therefore, was to determine the magnitude of 100 
the postural-induced changes in plasma [NO3-] and [NO2-] and PV at rest and following short-101 
duration exercise. The experiment was conducted both with and without prior dietary NO3- 102 
supplementation. We hypothesised that postural changes would alter plasma [NO3-] and [NO2-103 
] which would be inversely associated with the change in PV.  104 
 105 
2. Methods 106 
2.1. Participants 107 
Fourteen healthy and recreationally active participants (9 males and 5 females, age 27 ± 4 years, 108 
stature 176 ± 7 cm, and body mass 71 ± 11 kg) volunteered to participate in the study. Written 109 
informed consent was obtained from all individual participants included in the study. The study 110 
was approved by the School of Science and Sport Ethics Committee at The University of the 111 
West of Scotland and all procedures were performed in accordance with the 1964 Declaration 112 
of Helsinki and its later amendments. 113 
 114 
2.2. Study design 115 
Each participant attended the laboratory on two separate occasions with a minimum of six days 116 
between each visit. The experimental conditions were identical in each visit with the exception 117 
that the first trial was conducted with no dietary intervention (control; CON). The second was 118 
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preceded by ingestion of 3 x 70 ml of NO3--rich beetroot juice (Beet it, James White Drinks, 119 
UK) the day before and 2 x 70 ml, 2 h before the first blood sample (BR; total of ~31 mmol 120 
NO3-). Participants recorded their diet 24 h prior to CON and were asked to repeat this as 121 
closely as possible prior to BR. All trials were completed before 11 a.m. at the same time of 122 
day for each participant and following an overnight fast. Participants were instructed to avoid 123 
caffeine, foods high in NO2- and NO3- (e.g. green leafy vegetables and cured meats), alcohol, 124 
mouthwash, and strenuous exercise 24 h prior to the experiment. Participants were provided 125 
with one bottle of drinking water (Harrogate, UK) prior to CON trial and given instructions to 126 
arrive at the lab well hydrated. Participants recorded the volume of water ingested prior to CON 127 
and matched the volume prior to BR.  128 
 129 
2.3. Procedures 130 
Following standard anthropometric measurements (stature and body mass), participants lay in 131 
a supine posture to allow for the insertion of a cannula into the antecubital vein. Following 132 
cannulation, participants stood up for 10 min prior to lying supine to start the experimental 133 
trial. Baseline measurements (0 min) of venous blood, blood pressure (BP) and heart rate (HR) 134 
were recorded immediately. The measurement of BP was conducted using an automated 135 
sphygmomanometer (Omron M10, Kyoto, Japan) in triplicate during supine measures and in 136 
duplicate for the standing and seated measures. Mean arterial pressure (MAP) was calculated 137 
by the following equation: 138 
 139 
MAP = (2 x diastolic BP + systolic BP) / 3 140 
 141 
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Continuous measurement of HR was conducted using telemetry (Polar electro, Oy, Finland). 142 
Participants lay supine for a total of 30 min followed immediately by 2 min of standing, 2 min 143 
of sitting, and then 5 min of cycling at 60% of the age-predicted maximal heart rate. The 144 
duration of the standing, sitting, and exercise phases was kept brief to minimise 145 
pharmacokinetic alterations in plasma [NO3-] and [NO2-] in the BR trial. Plasma [NO2-] and 146 
[NO3-] are known to peak at ~2.5 h and ~1.5 h, respectively (Webb et al. 2008; Lundberg and 147 
Weitzberg 2009; Larsen et al. 2010; Wylie et al. 2013a; McIlvenna et al. 2017). Therefore, the 148 
end of the supine phase was designed to coincide with the peak in plasma [NO2-]. The 149 
experimental protocol reflects many exercise physiology research studies that incorporate both 150 
resting and exercise phases (Wylie et al. 2013b; Muggeridge et al. 2015; Sandbakk et al. 2015).  151 
 152 
Collection of venous blood, BP and HR were repeated throughout the experiment as detailed 153 
in Figure 1. The measurement of BP was not made during exercise due to difficulties in 154 
obtaining a stable measurement. Venous blood was collected in 10 ml aliquots and the cannula 155 
flushed with sterile 0.9% saline solution between samples to keep the line patent. Whole blood 156 
was initially separated into EDTA vacutainers (BD Vacutainer). One vacutainer was 157 
refrigerated at 4°C for the later analysis of haemoglobin concentration and haematocrit. All 158 
samples were analysed within 6 h. The other vacutainer was centrifuged at 4000 rpm and 4oC 159 
for 10 min within 3 min of collection (Pelletier et al. 2006; Bailey et al. 2009). The plasma was 160 
then separated, frozen at −80 °C, and analysed within 4 months of initial collection for 161 
determination of [NO3-] and [NO2-]. 162 
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 163 
Fig. 1.  Schematic of measurement time points for CON and BR trials. 164 
 165 
2.4. Plasma Nitrite and Nitrate analysis 166 
Measurements of [NO3-] and [NO2-] were made using ozone-based chemiluminescence 167 
(Rogers et al. 2005). For the measurement of [NO2-], tri-iodide reagent (2.5 ml glacial acetic 168 
acid, 0.5 ml of 18 Ω deionised water and 25 mg sodium iodide) and 100 μL of anti-foaming 169 
agent were placed into a customised glass purge vessel infused with nitrogen and inlet that was 170 
heated to 50 °C. This purge vessel was further connected to an NO analyser (Sievers NOA 171 
280i, Analytix, UK). A standard curve was produced by injecting 100 μL of NO2- solutions 172 
(1000 nM, 500 nM, 250 nM, 125 nM, and 62.5 nM) and control sample containing deionised 173 
water. The area under the curve (AUC) for the latter was subtracted from the NO2- solutions to 174 
account for NO2- in the water used for dilutions.  Following this, plasma samples were thawed 175 
in a water bath at 37 °C for 3 min and 100 μL of the sample was injected into the purge vessel 176 
in duplicate. The concentration of NO cleaved during the reaction was then measured by the 177 
NO analyser. The AUC was calculated using Origin software (version 7) and divided by the 178 
gradient of the slope. The coefficient of variation for the measurement of [NO2-] in the current 179 
study was 3%.  180 
 181 
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For the measurement of plasma [NO3-], vanadium reagent (32 mg of vanadium tri-chloride, 4 182 
ml of 1M hydrochloric acid and 500 μL of water) and 100 μL of anti-foaming agent were placed 183 
into the glass purge vessel and heated to 95 °C. A standard curve was produced by injecting 184 
25-50 μL of NO3- solutions (100 μM, 50 μM, 25 μM, 12.5 μM, and 6.25 μM) and a control 185 
sample containing deionised water. Plasma samples were thawed and de-proteinised (200 μL 186 
of sample, 400 μL of zinc sulphate in deionised water at 10% weight/volume and 400 μL of 187 
sodium hydroxide in deionised water at ratio of 1:1). Subsequently, 15-25 μL of the sample 188 
was injected into the purge vessel in duplicate and plasma [NO3-] calculated as previously 189 
described for the NO2- assay. The coefficient of variation for the measurement of [NO3-] in the 190 
current study was 6%.  191 
 192 
2.5. Determination of Plasma Volume Change 193 
To determine the haematocrit, a small volume of venous blood was extracted into heparinised 194 
capillary tubes that were sealed at the distal end with a wax seal. The capillary tubes were then 195 
spun for 8 min at 15,000 revolutions/min in a micro-haematocrit centrifuge before the 196 
haematocrit was measured in triplicate using a Hawksey haematocrit reader. The coefficient of 197 
variation for the measurement of haematocrit in the current study was 0.4%. Haemoglobin 198 
concentration was determined using the Randox colorimetric method (RX Monza, Randox 199 
Laboratories, UK). Briefly, 20 µL of whole blood was mixed in a cuvette with 2.5 ml of 200 
haemoglobin reagent before being incubated for 3 min at 25 oC. The haemoglobin 201 
concentration was determined by measuring absorbance when light at a wavelength of 546 nm 202 
was passed through the cuvette. The coefficient of variation for the measurement of 203 
haemoglobin in the current study was 2%. Total blood volume (TBV) and total PV (TPV) at 204 
baseline were estimated using the Nadler equations  (Nadler et al. 1962): 205 
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 206 
Males TBV = (0.3669 x height in meters3) + (0.03219 x body mass in kilograms) + 0.6041 207 
 208 
Females TBV = (0.3561 x height in meters3) + (0.03308 x body mass in kilograms) + 0.1833 209 
 210 
PV = TBV * (1 – Haematocrit) 211 
 212 
The percentage change (Δ) in PV was estimated using the change in haematocrit and 213 
haemoglobin values using the method described by Dill and Costill (1974). The PV values for 214 
each time point are expressed as estimated TPV and the percentage Δ from the baseline (0 min) 215 
sample (Fig. 4).   216 
 217 
2.6. Statistical Analysis 218 
All analyses were carried out using the Statistical Package for Social Sciences, Version 22 219 
(SPSS Inc., Chicago, IL, USA). GraphPad Prism version 7 (GraphPad Software Inc., San 220 
Diego, USA) was used to create the figures. Data are expressed as the mean ± standard 221 
deviation unless otherwise stated. The distribution of the data was tested using the Shapiro-222 
Wilk test. A one-way repeated-measures ANOVA was used to examine the differences 223 
between measurement points [NO3-], [NO2-], PV, HR and BP. Post-hoc analysis was used to 224 
determine the difference from the baseline and all other time points using a paired samples t-225 
tests with Bonferroni correction for multiple pairwise comparisons. The association between 226 
absolute and Δ plasma [NO3-], [NO2-], and TPV values was determined using Pearson’s 227 
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correlation coefficient. Statistical significance was declared when P<0.05. Probability values 228 
are expressed with 95% confidence intervals (95% CI) where appropriate.  229 
 230 
3. Results 231 
3.1. Nitrite 232 
Baseline values of [NO2-] were significantly elevated in the BR trial compared to the CON trial 233 
(P<0.01, 95% CI 154-320 nM, Fig. 2) and at all other time points. There was a significant main 234 
effect of measurement point on plasma [NO2-] in both trials (P<0.001). Plasma [NO2-] was not 235 
different to baseline after 10 min of lying supine in either condition (both P>0.05) but 236 
decreased significantly after 30 min (CON: P=0.02, 95% CI 5-82 nM; BR: P<0.01, 95% CI 237 
39-213 nM). In the CON trial, plasma [NO2-] increased from the 30 min supine time point upon 238 
standing (P<0.01, 95% CI 15-51 nM) and sitting (P<0.01, 95% CI 32-76 nM) and remained 239 
higher following exercise (P<0.05, 95% CI 7-89 nM). In the BR trial, plasma [NO2-] increased 240 
from 30 min supine upon standing (P<0.01, 95% CI 35-98 nM) and sitting (P<0.01, 95% CI 241 
58-251 nM). Following exercise, plasma [NO2-] was significantly reduced compared to sitting 242 
(P=0.02, 95% CI 13-180 nM) but was not different to the 30 min supine time point (P=0.14). 243 
Plasma [NO2-] was not correlated with TPV either for absolute (CON, R=0.04, P=0.74; BR, 244 
R=0.03, P=0.78) or Δ values (CON, R=-0.12, P = 0.31; BR R=-0.11, P = 0.39).  245 
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 246 
Fig. 2. Changes in mean ± SEM plasma [NO2-] expressed as absolute values (top) and 247 
percentage change from baseline (bottom). The graphical images at the top of the figure denote 248 
the supine, standing, seated, and exercise phases of the trial. a denotes a significant decrease 249 
compared to baseline (P<0.05). b denotes a significant increase compared to 30 min time point 250 
(P<0.05). All time points in the BR trial were significantly higher than the CON trial (P<0.01). 251 
 252 
3.2. Nitrate 253 
Plasma [NO3-] at baseline was higher in the BR trial compared to CON (P<0.01, 95% CI 395-254 
561 μM, Fig. 3) and at all other time points. There was a significant main effect of measurement 255 
point on plasma [NO3-] in the CON trial (P<0.01) but not the BR trial (P=0.20). In the CON 256 
trial, plasma [NO3-] was higher after exercise compared to 10 min of lying supine (P<0.01, 257 
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95% CI 4-24 μM) but was not different between any other measurement points. Plasma [NO3-258 
] was not correlated with TPV either for absolute (CON, R=-0.10, P=0.37; BR, R=-0.18, 259 
P=0.10) or Δ values (CON, R=-0.21, P=0.08; BR R=-0.02, P=0.86). 260 
 261 
Fig. 3.  Changes in mean ± SEM plasma [NO3-] expressed as absolute values (top) and 262 
percentage change from baseline (bottom). The graphical images at the top of the figure denote 263 
the supine, standing, seated, and exercise phases of the trial. a denotes a significant increase 264 
compared to 10 min time point (P<0.01). All time points in the BR trial were significantly 265 
higher than the CON trial (P<0.01). 266 
 267 
3.3. Plasma Volume  268 
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After 10 min of lying supine, PV increased from baseline in both conditions (all P<0.01, CON 269 
95% CI 0.09-0.51 L, BR 95% CI 0.12-0.42 L, Fig. 4) and remained elevated at the 30 min 270 
measurement point (all P<0.05, CON 95% CI 0.04-0.63 L, BR 95% CI 0.15-0.53 L). PV then 271 
declined significantly from the 30 min supine measurement upon standing, sitting, and exercise 272 
in both conditions (all P<0.05).  273 
 274 
Fig. 4.  Changes in mean ± SEM plasma volume expressed as absolute values (top) and 275 
percentage change from baseline (bottom). The graphical images at the top of the figure denote 276 
the supine, standing, seated, and exercise phases of the trial. a denotes a significant  increase 277 
compared to baseline (P<0.01). b denotes a significant decrease compared to 30 min of laying 278 
supine (P<0.05).  279 
 280 
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3.4. Blood Pressure  281 
Baseline measurements of MAP were significantly lower in the BR trial compared to CON 282 
(P<0.01, 95% CI 1-5 mmHg, Fig. 5) but was not different at any other time point. There was a 283 
significant main effect of time on MAP in both conditions (P<0.01). MAP was higher during 284 
standing compared to baseline (CON, P<0.01, 95% CI 4-13 mmHg; BR, P<0.01, 95% CI 4-16 285 
mmHg) and following 25 min lying supine (CON, P<0.01, 95% CI 6-14 mmHg; BR, P<0.01, 286 
95% CI 4-17 mmHg). In the CON trial, MAP was higher during sitting compared to lying 287 
supine for 25 min (P=0.04, 95% CI 0-10 mmHg). In the BR trial, MAP was higher during 288 
standing compared to sitting (P=0.03, 95% CI 0-7 mmHg). 289 
 290 
3.5 Heart Rate 291 
There was a significant main effect of time (P<0.01) on HR in both the CON and BR trials. 292 
HR was typically higher during the standing and sitting phases compared to the supine time 293 
points (all P<0.01). There was no difference in HR between sitting and standing measurements 294 
(both P>0.05). In both conditions, post-exercise HR was higher than all other time points (all 295 
P<0.01).  296 
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 297 
Fig. 5. Changes in mean ± SEM mean arterial pressure (top) and heart rate (bottom) expressed 298 
as absolute values. The graphical images at the top of the figure denote the supine, standing, 299 
seated, and exercise phases of the trial. a denotes a significant increase compared to baseline 300 
and 25 min time point (P<0.01). b denotes a significant increase compared to all other time 301 
points (P<0.05). c denotes significant increase compared to 25 min time point (P<0.05). 302 
Baseline measurements of mean arterial pressure were lower in the BR trial compared to the 303 
CON trial (P<0.01). 304 
 305 
4. Discussion 306 
To our knowledge, this study is the first to report that plasma [NO2-] is substantially altered by 307 
varying body posture while these changes have minimal impact on plasma [NO3-]. Here, we 308 
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report that plasma [NO2-] is increased during sitting and standing compared to lying supine 309 
which substantially extends our previous findings that plasma [NO2-] declines during a period 310 
of lying supine (Muggeridge et al. 2015).  311 
 312 
As expected, moving between different body postures resulted in consistent, marked and rapid 313 
changes in PV. Following a period of standing upright, PV increased by ~10% after 10 min in 314 
the supine posture. There was a further increase in PV at the 30 min time point, although this 315 
was of a much smaller magnitude (~13% from baseline). Previous data suggests that PV 316 
stabilises approximately 20 min in the supine posture (Hagan et al. 1978) which is pertinent 317 
when measuring the concentration of blood metabolites in exercise studies. On the other hand, 318 
moving from supine to standing resulted in an almost immediate (~2 min) reduction in PV 319 
which reduced further as participants continued to the seated posture. Again, the magnitude of 320 
the response was profound, with PV dropping by 6-10% following brief periods of standing 321 
and sitting from the end of the supine phase. A short period of exercise caused a further large 322 
reduction in PV which corresponded to a decline of ~19% from the end of the supine phase. 323 
These data are broadly in line with values reported elsewhere in the literature (Hagan et al. 324 
1978) although others (Hansen 1968; Lippi et al. 2015) have reported larger declines in PV 325 
during standing (~14%), likely due to longer period of time in this posture.  326 
 327 
These postural-induced alterations in PV are readily explainable and the likely mechanisms 328 
have been known for some time (Thompson et al. 1928). Adopting a standing posture increases 329 
local hydrostatic pressure, particularly in the lower limbs, which forces fluid and some 330 
molecules from the intravascular to the interstitial space (Krogh et al. 1932). The augmented 331 
reduction in PV during exercise is most likely caused by an increased intra-capillary pressure 332 
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in the contracting muscles (Hansen 1968). These fluid shifts do eventually stabilise due to 333 
counter pressure exerted by the tissue and an increase in the intravascular oncotic pressure 334 
(Youmans et al. 1934). As evidenced in the present study, the reduction in circulating blood 335 
volume and venous return can lead to an increase in HR and BP. It is important to note, 336 
however, that standing may initially reduce BP and transient changes in this response may vary 337 
between individuals (Eşer et al. 2007).  338 
  339 
For the first time, we demonstrate that plasma [NO2-] changes substantially between supine, 340 
standing and sitting phases. Where PV increases during the supine phase, [NO2-] decreases 341 
during lying supine and increases on standing and sitting. These data are perhaps not surprising 342 
given postural-induced PV shifts have previously been reported to alter the concentration of 343 
other constituents in the blood in a similar fashion (Thompson et al. 1928; Fawcett and Wynn 344 
1960; Lippi et al. 2015). Consequently, it might be expected that a considerable proportion of 345 
the change in plasma [NO2-] can be accounted for by a “dilution effect” where, for example, 346 
an increased PV reduces the measured concentration of the number of NO2- particles. However, 347 
there was no correlation between either absolute or Δ plasma [NO2-] and PV values suggesting 348 
plasma fluid shifts account for only a small proportion of the variance in [NO2-] during postural 349 
changes. Furthermore, plasma [NO3-] does not change uniformly as posture is altered and was 350 
not correlated with PV. Instead, it seems probable that postural-induced alterations in NO 351 
metabolism may account for these findings.  352 
 353 
In line with previous research, both plasma [NO2-] and [NO3-] were considerably elevated by 354 
ingestion of NO3--rich beetroot juice (198% and 1163%, respectively). However, given plasma 355 
[NO2-] is reported to peak ~2.5 h after acute ingestion of beetroot juice (Webb et al. 2008), it 356 
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is perhaps surprising that plasma [NO2-] in the present study declined during the supine phase 357 
of the BR trial to the same extent as CON (i.e. 2 – 2.5 h after ingestion). Nevertheless, we 358 
(McIlvenna et al. 2017) and others (James et al. 2015) have previously demonstrated that 359 
plasma NO2- pharmacokinetics following dietary NO3- ingestion appear to vary substantially 360 
between individuals. For example, Wylie and colleagues (2013a) reported that time taken for 361 
plasma [NO2-] to peak following administration of a similar dose of NO3--rich beetroot juice 362 
ranged between 77 and 213 min. Therefore, it is plausible that while dietary-derived NO2- was 363 
still increasing in the plasma in some participants, it was declining in others.   364 
 365 
Measurement of plasma [NO2-] and [NO3-] is further complicated by the fact that changes in 366 
posture also alter the rate of endogenous NO production. Shear stress is a frictional force 367 
exerted by blood moving across the endothelium and is reported to increase during standing 368 
compared to sitting (Morishima et al. 2017). Endothelial cells rapidly respond to shear stress 369 
with an acute increase in intracellular calcium that enhances the binding of calmodulin to eNOS 370 
and increases eNOS  activity and NO production (Boo and Jo 2003; Rassaf et al. 2006). On the 371 
contrary, moving from a supine to a seated positon has been demonstrated to reduce shear rate 372 
in young but not old participants (Trinity et al. 2015). Given that shear rate was not measured 373 
in the current study, we can only speculate as to how this may have impacted endogenous 374 
synthesis of NO and related metabolites. Conversion of NO to NO3- by heme proteins in the 375 
blood and tissues occurs fairly rapidly (Shiva et al. 2006), such that NO3- is considered to be 376 
the major breakdown product in the presence of sufficient amounts of O2 (Kelm 1999). 377 
Conversely, NO can be oxidised to NO2- via various oxidants in plasma and tissues (Shiva et 378 
al. 2006).  It should also be noted that a considerable portion of NO2- and NO3- are stored in 379 
tissues. In rodents, the liver, blood, and skeletal muscle contain equivalent amounts of NO2- 380 
(~0.5 – 0.7 nmol/g) whereas NO3- is considerably higher in muscle (~200 nmol/g) compared 381 
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to blood (~80 nmol/g) and the liver (~10 nmol/g) (Piknova et al. 2015). Furthermore, 382 
Nyakayiru et al. (2017) have recently shown that ingestion of sodium NO3- results in a 383 
substantial and sustained increase in muscle [NO3-], with reported values exceeding those in 384 
plasma. However, muscle [NO2-] was below the detection limit both before and after NO3- 385 
supplementation. Therefore, when considering the impact of postural-induced fluid shifts in 386 
the context of measuring [NO2-] and [NO3-], we must also factor in the change in endogenous 387 
NO production, the oxidation of NO to various metabolic endpoints, and the transfer of these 388 
metabolites to and from different tissues.  389 
  390 
Data from this study also demonstrates that short-duration sub-maximal cycling exercise leads 391 
to a reduction in plasma [NO2-] in both conditions but a variable response in plasma [NO3-]. 392 
Although plasma [NO3-] did not differ statistically between time points overall, there was a 393 
substantial increase from pre- to post-exercise in the CON trial and a reduction in the BR trial. 394 
The reduction in plasma [NO2-] is consistent with some (Larsen et al. 2007; Kelly et al. 2014), 395 
but not all (Larsen et al. 2010) previous studies and potentially results from an increased 396 
conversion of NO2- to NO during exercise. Differences between study cohorts and the intensity 397 
and duration of the exercise protocols may explain the inconsistencies in these data. Cosby and 398 
colleagues (2003) suggest that NO2- is a major bioavailable pool of NO and present data 399 
demonstrating an increased reduction of NO2- to NO by deoxyhemoglobin during exercise. 400 
Furthermore, in animal studies, the initiation of exercise has been shown to increase the 401 
demand for NO and upregulate eNOS activity (Maiorana et al. 2003). Therefore, post-exercise 402 
changes in plasma [NO2-] and [NO3-] in dietary NO3- supplementation studies must be 403 
interpreted cautiously due to the aforementioned pharmacokinetics of these metabolites and the 404 
individual variability in the response (James et al. 2015; McIlvenna et al. 2017). 405 
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 406 
Although the precise mechanisms explaining the alterations in plasma [NO2-] remain unclear, 407 
the magnitude of the change in this outcome during the adoption of different postures highlights 408 
the importance of standardising posture in experimental trials where this outcome is important.  409 
Indeed, an inconsistent approach to the posture of participants during blood collection may at 410 
least partly explain why measurements of plasma [NO3-] are comparable between different 411 
studies in healthy participants while [NO2-] varies considerably. The present study is not 412 
without limitations as the phases of sitting, standing, and exercise were very brief and the fate 413 
of the ingested NO3- is impossible to determine without more advanced measurement methods. 414 
Furthermore, the order of the trials was not randomised and nor was there inclusion of a placebo 415 
condition that required the ingestion of a matched volume of NO3--depleted beetroot juice. 416 
However, our data demonstrates the proportional change in PV, [NO3-] and [NO2-] were 417 
consistent between BR and CON conditions suggesting these experimental limitations do not 418 
diminish confidence in the findings. Notwithstanding, there are two primary recommendations 419 
that emanate from this work. Firstly, if differences in [NO2-] are to be compared either within 420 
or between participants in an experimental trial, participants should be lying supine for a 421 
standardised period of time before blood collection. For baseline measurements the supine 422 
period should be a minimum of 20 – 30 min. For post-exercise measurements the supine period 423 
should be brief but standardised. Secondly, the posture of participants during blood collection 424 
and the duration that this posture was maintained before blood collection should be clearly 425 
documented in research manuscripts to allow better comparison of data between studies. 426 
 427 
5. Conclusion  428 
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The principal finding from this study is that posture has a profound impact on the concentration 429 
of plasma NO2- regardless of whether [NO2-] was normal or elevated by dietary NO3- 430 
supplementation. The lack of correlation between PV and [NO2-] suggests that fluid shifts 431 
cannot solely account for this response. While postural alterations in shear stress and 432 
endogenous NO production may be contributing factors, we do not have experimental data to 433 
support this notion. Nevertheless, researchers should standardise the posture of participants at 434 
rest and post exercise when multiple blood samples are to be collected and fully document 435 
these procedures during dissemination of their data.  436 
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